Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer

BACKGROUND: Perturbation of the CDK4/6 pathway is frequently observed in advanced bladder cancer. We investigated the potential of targeting this pathway alone or in combination with chemotherapy or immunotherapy as a therapeutic approach for the treatment of bladder cancer METHODS: The genetic alte...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cancer Immunol Immunother
Main Authors: Long, Qilai, Ma, Ai-Hong, Zhang, Hongyong, Cao, Zhixiu, Xia, Roger, Lin, Tzu-Yin, Sonpavde, Guru P., de Vere White, Ralph, Guo, Jianming, Pan, Chong-Xian
Format: Artigo
Jezik:Inglês
Izdano: Springer Berlin Heidelberg 2020
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7572640/
https://ncbi.nlm.nih.gov/pubmed/32506263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00262-020-02609-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki